Medical Gas Research, Год журнала: 2024, Номер unknown
Опубликована: Ноя. 8, 2024
Schizophrenia is a chronic devastating psychiatric disease characterized by high recurrence rate. Pharmacological management of this disorder appears disappointing since it associated with lack efficacy for negative symptoms and cognitive deficits, typical features schizophrenia, the presence severe undesired side effects. Thus, novel molecules low toxicity treatment schizophrenia are urgently needed. The involvement gaseous molecule nitric oxide in pathogenesis well documented concentrations disease. Therefore, chemicals able to normalize levels, such as donors, might be useful type schizophrenia. Molsidomine donor under investigation antischizophrenia agent. aim review critically evaluate potential
Язык: Английский